Researchers from Saint Mary’s Hospital, part of MFT, have been awarded an American Association for Cancer Research Award for their pioneering work on Lynch-syndrome associated endometrial cancer.
A simple, safe and accurate test that identifies women with womb cancer from a sample taken from the vagina has been developed by clinician scientists in Manchester.
A hormone blood test, developed at MFT can determine the effectiveness of anastrozole, the recommended preventative treatment for post-menopausal women at high risk of developing breast cancer.
Babies at MFT have been part of groundbreaking research which found that a single dose of a treatment for a respiratory infection in infants can help cut hospital admissions by more than 80 per cent.
New research has shown that empowering women to self-manage a common treatment for pelvic organ prolapse leads to fewer complications and could save the NHS more than £560 per patient.
More than 1,100 pregnant women on the North Manchester site of Saint Mary’s Managed Clinical Service, have taken part in a rapid beside test to protect newborns from life-threatening illnesses.